- Home
- KTTA vs ALCE Comparison
KTTA vs ALCE Comparison
Compare KTTA & ALCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- ALCE
- Stock Information
- Founded
- KTTA 2020
- ALCE 2019
- Country
- KTTA United States
- ALCE United States
- Employees
- KTTA 8
- ALCE N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- ALCE Power Generation
- Sector
- KTTA Health Care
- ALCE Utilities
- Exchange
- KTTA Nasdaq
- ALCE Nasdaq
- Market Cap
- KTTA 3.4M
- ALCE 3.7M
- IPO Year
- KTTA 2021
- ALCE N/A
- Fundamental
- Price
- KTTA $2.64
- ALCE $0.79
- Analyst Decision
- KTTA
- ALCE
- Analyst Count
- KTTA 0
- ALCE 0
- Target Price
- KTTA N/A
- ALCE N/A
- AVG Volume (30 Days)
- KTTA 57.9K
- ALCE 674.0K
- Earning Date
- KTTA 11-13-2024
- ALCE 11-19-2024
- Dividend Yield
- KTTA N/A
- ALCE N/A
- EPS Growth
- KTTA N/A
- ALCE N/A
- EPS
- KTTA N/A
- ALCE N/A
- Revenue
- KTTA N/A
- ALCE N/A
- Revenue This Year
- KTTA N/A
- ALCE N/A
- Revenue Next Year
- KTTA N/A
- ALCE N/A
- P/E Ratio
- KTTA N/A
- ALCE N/A
- Revenue Growth
- KTTA N/A
- ALCE N/A
- 52 Week Low
- KTTA $2.57
- ALCE $0.74
- 52 Week High
- KTTA $9.40
- ALCE $162.75
- Technical
- Relative Strength Index (RSI)
- KTTA 34.15
- ALCE 22.06
- Support Level
- KTTA $2.57
- ALCE $0.98
- Resistance Level
- KTTA $3.07
- ALCE $1.23
- Average True Range (ATR)
- KTTA 0.21
- ALCE 0.11
- MACD
- KTTA 0.01
- ALCE 0.02
- Stochastic Oscillator
- KTTA 14.49
- ALCE 4.29
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.